There are multiple links in the WP article to the original studies.
underwriting
In Type 1 Diabetes, Insulin Pump Provides Greater CV Mortality Benefit Than Daily Injections — Physician’s First Watch
Epilepsy Increases Mortality Risk in Pregnant Women | Medpage Today
Sarah C. MacDonald, BSc, of the Harvard T. H. Chan School of Public Health, and colleagues, found that after adjusting for several confounders, women with epilepsy had a more than 10-fold increased risk of death during delivery hospitalization (adjusted odds ratio 11.46, 95% CI 8.64-15.19) compared with women without epilepsy (80 deaths per 100,000 pregnancies versus six deaths in 100,000 pregnancies).
via Epilepsy Increases Mortality Risk in Pregnant Women | Medpage Today.
FDA Stiffens Warning on NSAID Cardiovascular Risk | Medpage Today
FDA Stiffens Warning on NSAID Cardiovascular Risk | Medpage Today.
Thought I would add a link to the actual FDA alert.
NSAIDs can increase the risk of heart attack or stroke in patients with or without heart disease or risk factors for heart disease. A large number of studies support this finding, with varying estimates of how much the risk is increased, depending on the drugs and the doses studied.
Vital Signs: Demographic and Substance Use Trends Among Heroin Users — United States, 2002–2013
Even Light Activity Can Boost Seniors’ Health – MedicineNet
Even Light Activity Can Boost Seniors’ Health – MedicineNet.
It really is amusing the stuff that grabs your attention the older you get.
Excess Risk of Dying From Infectious Causes in Those With Type 1 and Type 2 Diabetes
Men With RA Have Double the Rate of All-Cause Mortality | Medpage Today
El Salvador Travel Warning – June 2015
PCSK9 Inhibitors
There’s also the issue of cost. The medicines are expected to come with a price tag of $7,000 to $12,000 per patient per year, according to the Wall Street Journal’s Pharmalot blog, costing the US health system as much as $23 billion a year. “These injectable drugs are already viewed by payers as potential budget busters along the lines of treatments for hepatitis C and some cancers,” Ed Silverman wrote.
via There’s still a lot we don’t know about the new cholesterol-lowering drugs – Vox.
You must be logged in to post a comment.